Claims
- 1. A method of reducing the risk of microbial infection and also of combating an established microbial infection which is established first in the nasal mucosa area comprising the application of a nasal spray solution within the nose, said nasal spray solution comprising an aqueous solution having;from about 0.5 ppmw to about 50,000 ppmw of sodium hypochlorite; from about 0.1 ppmw to 160,000 ppmw of a salt selected from one or more of sodium bromide and sodium iodide; from about 55 ppmw to 75,000 ppmw of sodium chloride; from about 1 ppmw to about 50,000 ppmw of iodine; from about 0.01 wt. % to about 5 wt. % of glycerin.
Parent Case Info
This patent application is based upon U.S. Provisional Application Ser. No. 60/365,926, filed Mar. 20, 2002.
US Referenced Citations (16)
Provisional Applications (1)
|
Number |
Date |
Country |
|
60/365926 |
Mar 2002 |
US |